Two Pharma Firms in India Begin Phase IV Efficacy Trial for COVID-19 Drug, an Industrial Info Market Brief
Attachment: India COVID drug 0920
India's Central Drugs Standard Control Organisation (CDSCO) recently granted approval to pharmaceutical majors Cipla Limited and Optimus Pharma Limited to conduct Phase IV trials for Favipiravir, the most sought-after medicine in the treatment of mild to moderate symptoms of COVID-19.
